Earnings History Data for BioStem Technologies, Inc. (BSEM) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
BioStem Technologies, Inc.
BioStem Technologies Inc. is a regenerative medicine company. It focused on the development, manufacture and commercialization of placental derived biologics. The company's portfolio of brands includes VENDAJE(R), VENDAJE AC(R) and VENDAJE OPTIC(R). BioStem Technologies Inc. is based in POMPANO BEACH, FLORIDA.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | PM | BSEM | BioStem Technologies, Inc. | 338.00 | 0.32 | 0.31 | 0.00 | BioStem Technologies GAAP EPS of $0.32, revenue of $82.55M [11/12/2024 11:46 AM] |
23.40 | -1.58 (-6.33%) |
0.0 | 0.0 (0.00%) |
2.34 - 28.26 | 100,289 | 0 | 0 | ||
| 12-08-2024 | AH | BSEM | BioStem Technologies, Inc. | 160.00 | 0.30 | 0.12 | 0.00 | BioStem Technologies GAAP EPS of $0.39 beats by $0.27, revenue of $74.5M beats by $30.5M [8/12/2024 4:31 PM] |
13.61 | 1.11 (8.88%) |
0.0 | 0.0 (0.00%) |
1.21 - 15.50 | 175,963 | 0 | 0 | ||
| 14-05-2024 | PM | BSEM | BioStem Technologies, Inc. | 152.00 | 0.20 | 0.74 | 0.00 | BioStem Technologies GAAP EPS of $0.20, revenue of $41.9M [5/15/2024 9:39 AM] |
9.70 | 0.43 (4.64%) |
0.0 | 0.0 (0.00%) |
1.20 - 15.50 | 42,538 | 0 | 0 | ||
| 01-04-2024 | AH | BSEM | BioStem Technologies, Inc. | 196.00 | -0.14 | 0.47 | 0.00 | BioStem Technologies reports Q4 results [4/1/2024 4:33 PM] |
13.23 | -2.27 (-14.65%) |
0.0 | 0.0 (0.00%) |
1.20 - 15.50 | 55,917 | 0 | 0 | ||
| 13-11-2023 | AH | BSEM | BioStem Technologies, Inc. | 42.00 | 0.03 | -0.18 | 0.00 | BioStem Technologies GAAP EPS of $0.03, revenue of $3.6M [11/14/2023 10:58 AM] |
3.24 | 0.15 (4.85%) |
0.0 | 0.0 (0.00%) |
1.20 - 3.80 | 7,045 | 0 | 0 | ||